申请人:Orphagen Pharmaceuticals, Inc.
公开号:US20170267712A1
公开(公告)日:2017-09-21
Methods for modulating (inhibiting or stimulating) retinoid-related orphan receptor γ (RORγ) activity. This modulation has numerous effects, including inhibition of T
H
-17 cell function and/or T
H
-17 cell activity, and inhibition of re-stimulation of T
H
-17 cells, which are beneficial to treatment of inflammation and autoimmune disorders. Stimulation of RORγ results in stimulation of T
H
-17 cell function and/or activity which is beneficial for immune-enhancing compositions (e.g., vaccines).